Skip to main content
GutCited

Bacillus coagulans para Irritable Bowel Syndrome (IBS)

B

Reduces abdominal pain, bloating, and diarrhea in IBS. Spore-forming nature provides excellent stability and gastric acid survival.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dbacillus\u002Dcoagulans\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Conclusión

Reduces abdominal pain, bloating, and diarrhea in IBS. Spore-forming nature provides excellent stability and gastric acid survival.

Key Study Findings

Meta-Analysis
Strain-Specific Systematic Review with Meta-Analysis of Probiotics Efficacy in the Treatment of Irritable Bowel Syndrome.
Dose: None vs: placebo Outcome: improvement in key IBS symptoms Efecto: None None

Población: patients with IBS from 32 RCTs evaluating 10 probiotic strains

Randomized Controlled Trial n=61 4 weeks Double-blind
Effects of a Bacillus subtilis HU58 and Heyndrickxia faecalis SC208 spore-forming probiotic formula on gastrointestinal …
Dose: None vs: Placebo Outcome: Abdominal pain (NRS) and stool consistency (BSFS) Efecto: None P = 0.003 (pain); P = 0.035 (s

Población: Adults with diarrhoea-predominant IBS (IBS-D)

Randomized Controlled Trial n=100 12 weeks
Role of Bacillus coagulans (Heyndrickxia coagulans)BCP92 in managing irritable bowel syndrome: A randomized, double-blind, multicenter, …
Dose: None vs: Control Outcome: Pain outcomes Efecto: None P < .001

Población: IBS patients

Meta-Analysis
Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Review …
Dose: Various probiotic strains/mixtures vs: Placebo Outcome: Outcome-specific efficacy ranking in IBS Efecto: None None

Población: Adults with IBS (RCTs)

Randomized Controlled Trial 12 weeks Double-blind
The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or Bacillus coagulans in …
Dose: 20.5% vs: placebo Outcome: IBS symptom improvement Efecto: None p = 0.038

Población: Adults with IBS

Review
Oral microbial shift induced by probiotic Bacillus coagualans along with its clinical perspectives.
Dose: None vs: None Outcome: colitis/IBD severity Efecto: None None

Población: None

Key Statistics

3

Estudios

400

Participantes

Positive

B

Calificación

Referenced Papers

Beneficial microbes 2019 45 citas
Beneficial microbes 2019 29 citas

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosificaciones de uso común

general:
1-2 billion CFU/day
ibssupport:
2 billion CFU/day (GBI-30 6086 strain)

Límite superior: Well-tolerated up to 6 billion CFU/day in clinical trials

Dosificaciones estudiadas en la investigación

Dosificación Duración Efecto N
None -- Positive --
None 4 weeks Positive 61
None 12 weeks Positive 100
Various probiotic strains/mixtures -- Positive --
20.5% 12 weeks Positive --
None -- Positive --
None -- Mixed --
None -- Mixed --

Mejor momento para tomar: With meals for optimal spore germination and colonization

Safety & Side Effects

Efectos secundarios reportados

  • Mild gas during initial use (generally less than other probiotics due to spore form)
  • Occasional bloating
  • Rare loose stools

Interacciones conocidas

  • Antibiotics (spore form is more resistant than vegetative probiotics, but spacing still recommended)
  • Immunosuppressants (theoretical risk in immunocompromised patients)

Ingesta máxima tolerable: Well-tolerated up to 6 billion CFU/day in clinical trials

Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.

Frequently Asked Questions

Does Bacillus coagulans help with Irritable Bowel Syndrome (IBS)?
Based on 3 studies with 400 participants, there is moderate evidence from clinical studies that Bacillus coagulans may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is B (Good Evidence).
How much Bacillus coagulans should I take for Irritable Bowel Syndrome (IBS)?
Studies have used various dosages. A commonly studied range is 1-2 billion CFU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Bacillus coagulans?
Reported side effects may include Mild gas during initial use (generally less than other probiotics due to spore form), Occasional bloating, Rare loose stools. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Bacillus coagulans and Irritable Bowel Syndrome (IBS)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 3 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.

Related Evidence

Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.